Hennion & Walsh Asset Management, Inc. - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 143 filers reported holding KRYSTAL BIOTECH INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$5,895,236
+100967.0%
50,821
+2.3%
0.38%
+8.7%
Q2 2023$5,833
+61.0%
49,682
+9.8%
0.35%
+55.9%
Q1 2023$3,622
+1.1%
45,235
+0.1%
0.22%
+0.5%
Q4 2022$3,581
-99.9%
45,203
+11.2%
0.22%
+18.8%
Q3 2022$2,834,000
+30.8%
40,656
+23.2%
0.19%
+38.8%
Q2 2022$2,166,000
+39.3%
32,993
+41.2%
0.13%
+61.4%
Q1 2022$1,555,000
+57.2%
23,368
+65.3%
0.08%
+69.4%
Q4 2021$989,00014,1370.05%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q4 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$68,951,0005.53%
S Squared Technology, LLC 85,215$6,565,0003.10%
First Light Asset Management, LLC 491,511$37,866,0002.51%
Soleus Capital Management, L.P. 166,844$12,854,0002.32%
Redmile Group, LLC 2,060,132$158,713,0002.24%
Nicholas Investment Partners, LP 304,689$23,473,0001.64%
HighMark Wealth Management LLC 17,192$1,324,0001.06%
DSAM Partners (London) Ltd 70,274$5,414,0001.00%
Artal Group S.A. 500,000$38,520,0000.68%
Hood River Capital Management LLC 237,882$18,326,0000.59%
View complete list of KRYSTAL BIOTECH INC shareholders